The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2025

Filed:

Mar. 04, 2024
Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Inventors:

Alex Anping Yu, Safety Harbor, FL (US);

James Grayson, Toronto, CA (US);

Robert W. Childers, New Port Richey, FL (US);

Assignees:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 1/16 (2006.01); A61M 1/14 (2006.01); A61M 1/28 (2006.01); A61M 1/34 (2006.01); B01D 61/30 (2006.01); B01D 61/32 (2006.01); G16H 20/40 (2018.01);
U.S. Cl.
CPC ...
A61M 1/282 (2014.02); A61M 1/155 (2022.05); A61M 1/159 (2022.05); A61M 1/16 (2013.01); A61M 1/1603 (2014.02); A61M 1/28 (2013.01); A61M 1/281 (2014.02); A61M 1/287 (2013.01); A61M 1/341 (2014.02); B01D 61/30 (2013.01); B01D 61/32 (2013.01); G16H 20/40 (2018.01); A61M 1/1522 (2022.05); A61M 2205/18 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/502 (2013.01); A61M 2230/005 (2013.01); A61M 2230/30 (2013.01);
Abstract

An example peritoneal dialysis system is disclosed. The example peritoneal dialysis system includes at least one pump and a memory device configured to store therapy prescriptions including a first ultrafiltration ('UF') therapy prescription for removing ultrafiltrate from a patient, and a second UF therapy prescription for removing less ultrafiltrate from the patient compared to the first UF therapy prescription. The system further includes a logic implementer configured to receive UF removed data, use the UF removed data to form or update a moving average UF removed trend, and compare the moving average UF removed trend to an expected UF removal trend or an expected UF removal minimum value. When the moving average UF removed trend is below the expected UF removal trend or the expected UF removal minimum value, the logic implementer provides a recommendation that the first UF therapy prescription should be selected for a next peritoneal dialysis treatment.


Find Patent Forward Citations

Loading…